[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367533-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367533-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cell-mediated-mucositis-of-the-oral-cavity-narrative-review-on-etiology-clinicopathological-aspects-and-malignant-transformation","Cell-mediated mucositis of the oral cavity - narrative review on etiology, clinicopathological aspects and malignant transformation","","Cell-mediated mucositis is a type IV hypersensitivity driven by cytotoxic CD8+ T lymphocytes that target keratinocytes of the basal layer, initiating immune activation. Evidence supports an increased risk of oral cancer among patients diagnosed with cell-mediated mucositis. This narrative review analyzes etiology, clinical and histological features, management, and malignant transformation across subtypes including oral lichen planus, oral lichenoid lesions, graft-versus-host disease, and lupus-associated oral lesions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cell-mediated-mucositis-of-the-oral-cavity-narrative-review-on-etiology-clinicopathological-aspects-and-malignant-transformation/367533/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cell-mediated-mucositis-of-the-oral-cavity-narrative-review-on-etiology-clinicopathological-aspects-and-malignant-transformation/367533.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What immunological mechanism defines cell-mediated mucositis?","Question",{"text":63,"@type":64},"Cell-mediated mucositis represents a type IV hypersensitivity in which cytotoxic CD8+ T lymphocytes attack keratinocytes of the basal layer, with additional immune-mediated aggression involving the basement membrane.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which oral conditions are included in this review?",{"text":68,"@type":64},"The review covers subtypes such as oral lichen planus, oral lichenoid lesions, graft-versus-host disease, and oral lesions associated with lupus erythematosus, along with discussion of related malignant transformation risks.",{"name":70,"@type":61,"acceptedAnswer":71},"How does malignant transformation risk vary across conditions?",{"text":72,"@type":64},"Reported transformation rates range from about 0.44%–2.28% for oral lichen planus and 1.20%–3.80% for oral lichenoid lesions, rising to higher-risk groups such as oral epithelial dysplasia and proliferative verrucous leukoplakia.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367533,1790257313,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","PATHOLOGICA 2025;117:84-100; DOI: 10.32074/1591-951X-1093  \nReceived: September 15, 2024  \nAccepted: December 28, 2025  \nCorrespondence  \nGiulia Querzoli  \nE-mail: [querzoligiulia@gmail.com](querzoligiulia@gmail.com)  \nHow to cite this article: Querzoli G, Gabusi A, Gissi DB, et al. Cell-mediated mucositis of the oral cavity: narrative review on etiology, clinico-pathological aspects and malignant transformation. Pathologica 2025;117:84- 100. [https://doi.org/10.32074/1591-951X-1093](https://doi.org/10.32074/1591-951X-1093)  \n© Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology  \n OPEN ACCESS  \nThis is an open access journal distributed in accordance with the CC-BY-NC-ND (Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International) license: the work can be used by mentioning the author and the license, but only for non-commercial purposes and only in the original version. For further information: [https://creativecommons](https://creativecommons). org/licenses/by-nc-nd/4.0/deed.en  \nReview  \nCell-mediated mucositis of the oral cavity: narrative review on etiology, clinicopathological aspects and malignant transformation  \nGiulia Querzoli1 , Anna Gabusi2 Davide Bartolomeo Gissi2 , Sara Bassani3 , Roberto Rossi2 , Achille Tarsitano4,5 , Lucio Montebugnoli2 , Maria Pia Foschini6  \n1 Pathology Unit, IRCCSAzienda Ospedaliero Universitaria di Bologna, Bologna, Italy; 2 Department of Biomedical and Neuromotor Sciences, Section of Oral Sciences, University of Bologna, Bologna, Italy;  \n3 Otolaryngology-Head and Neck Surgery Department, University of Verona, Verona, Italy; 4 Oral and Maxillofacial Surgery Unit, IRCCSAzienda Ospedaliero-Universitaria di Bologna, Italy; 5 Department of Biomedical and Neuromotor Sciences, Section of Maxillo-facial Surgery at Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy; 6 Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology at Bellaria Hospital, University of Bologna, Bologna, Italy  \nSummary  \nCell-mediated mucositis is the expression of a type IV hypersensitivity, in which cytotoxic CD8+ T lymphocytes attack the keratinocytes of the basal layer responsible for activating the immune response. There is sufficient evidence for an increased risk of oral cancer inpatients with a diagnosis cell mediated mucositis. This review aims to examine the etiology, clinical-histological features, management and malignant transformation of a group of cellmediated mucositis, including oral lichen planus, oral lichenoid lesions, Graft versus host disease, oral lesion of lupus erythematous.  \nThe authors conducted a literature review, selecting relevant studies based on their novelty, applicability, and impact. The text highlights the varying rates of malignant transformation associated with different oral conditions. For oral lichen planus, the risk of transformation ranges from 0.44% to 2.28%, while for oral lichenoid lesions (OLLs), the rate is slightly higher, between 1.20% and 3.80%. Conditions like graft-versus-host disease are linked toa malignant transformation rate of 3.47%, and oral lesions associated with lupus erythematosus carry a similar risk at 3.3%, often involving squamous cell carcinoma of the lips. In cases of oral epithelial dysplasia, the risk increases significantly with severity, reaching 24.1% for severe dysplasia. The condition with the highest malignant potential is proliferative verrucous leukoplakia, with a transformation rate estimated at 49.5%. These findings underscore the importance of accurate diagnosis, vigilant monitoring, and the development of new therapeutic strategies. Recent advancements in treatments, such as nivolumab and imiquimod, show promise in early trials. These approaches aim to move beyond passive observation, shifting towards personalized medical interventions to reduce the risk of malignant transformation in high-risk","cbCaisBNRv2qbQ3L","https://ap.wps.com/l/cbCaisBNRv2qbQ3L","pdf",4756448,17,"English","# Summary\n# Introduction\n## Immunopathogenesis of CMM\n## Histological interface pattern (ICMM)\n# Malignant transformation risk by oral conditions\n# Clinical implications and emerging therapies","[{\"question\":\"What immunological mechanism defines cell-mediated mucositis?\",\"answer\":\"Cell-mediated mucositis represents a type IV hypersensitivity in which cytotoxic CD8+ T lymphocytes attack keratinocytes of the basal layer, with additional immune-mediated aggression involving the basement membrane.\"},{\"question\":\"Which oral conditions are included in this review?\",\"answer\":\"The review covers subtypes such as oral lichen planus, oral lichenoid lesions, graft-versus-host disease, and oral lesions associated with lupus erythematosus, along with discussion of related malignant transformation risks.\"},{\"question\":\"How does malignant transformation risk vary across conditions?\",\"answer\":\"Reported transformation rates range from about 0.44%–2.28% for oral lichen planus and 1.20%–3.80% for oral lichenoid lesions, rising to higher-risk groups such as oral epithelial dysplasia and proliferative verrucous leukoplakia.\"}]","Cell-mediated mucositis of the oral cavity - narrative review on etiology, clinicopathological aspects and malignant transformation | PDF",1790171244,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c4068814fe10537b1bb62aee0768346.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/467cc14285d576b83f05e7166420703a.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c1f5b0dae0e5539347e73dd3869c267.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e50b1475495be89446db0922f3a3bab.webp",980,1306]